Cargando…
The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis
BACKGROUND: Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease that often progresses to end-stage liver disease and/or the development of hepatobiliary neoplasia. Lack of prognostic tools and treatment options for PSC is driven in part by our poor understanding of its...
Autores principales: | Ali, Ahmad Hassan, Juran, Brian D., Schlicht, Erik M., Bianchi, Jackie K., McCauley, Bryan M., Atkinson, Elizabeth J., Lazaridis, Konstantinos N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465725/ https://www.ncbi.nlm.nih.gov/pubmed/34563121 http://dx.doi.org/10.1186/s12876-021-01930-2 |
Ejemplares similares
-
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data
por: Hu, Chang, et al.
Publicado: (2023) -
External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018) -
Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
por: Grant, Caroline W, et al.
Publicado: (2023) -
IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids
por: Garcia Moreno, Ana Sofia, et al.
Publicado: (2023) -
PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)
por: Stinton, Laura M., et al.
Publicado: (2014)